13. •Reactions of Heme synthesis
ALA synthesis
Formation of Porphobillinogen
Formation of Hydroxymethylbilane
Formation of Uroporphyrinogen
Synthesis of Coproporphyrinogen
Synthesis of Protoporphyrinogen
Generation of Protoporphyrin
Generation of Heme
23. • Drugs like barbiturates induce heme synthesis.
• Large no. of drugs results in a significant increase in hepatic
ALAS1 activity. These drugs are metabolized by the
microsomal CYP (cytochrome P450) monooxygenase system, a
hemeprotein oxidase system found in liver.
• In response to these drugs, the synthesis of CYP proteins inc.
and dec conc. Of heme.
• ALA dehydratase are inhibited by lead. So lead toxicity causes
anemia.
24.
25. 1. Major sites of heme synthesis liver and bone marrow
(erythroblasts).
2. Matured red blood cells have no mitochondria, so
can’t synthesize heme.
3. The substrates mainly include succinyl-CoA, glycine,
Fe2+ .
3. First and last 3 reactions take place in mitochondria,
others in cytoplasm
Summary
Editor's Notes
Biosynthesis of porphobilinogen. ALA synthase occurs in the mitochondria,
whereas ALA dehydratase is present in the cytosol.
The substrates are succinyl-CoA and glycine
The product is delta-aminolevulinic acid (ALA).
An essential cofactor is pyridoxal phosphate (vit B-6).
This is the rate-limiting reaction of heme synthesis in all
tissues, and it is therefore tightly regulated.
The substrates are two molecules of ALA.
The product is porphobilinogen, the first pyrrole.
ALA dehydratase is a -SH containing enzyme.
• It is very susceptible to inhibition by lead.
Conversion of porphobilinogen to uroporphyrinogens.
Uroporphyrinogen synthase I is also
called porphobilinogen (PBG) deaminase or hydroxymethylbilane
(HMB) synthase.
Decarboxylates the acetic acid groups, converting them to
methyl groups.
Catalyzes the conversion of two propionic acid groups to vinyl
Groups
Protoporphyrinogen IX oxidase converts the methylene
bridges between the pyrrole rings to methenyl bridges.
Ferrochelatase adds Fe++ to protoporphyrin IX, forming
heme.
• The enzyme requires Fe++, ascorbic acid and cysteine
(reducing agents).
• Ferrochelatase is inhibited by lead.